Frederick Ruthardt, MD
Gastroenterology · Uniontown, PANPI 1679671093
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 122 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 49.4% of the total. Reporting peaked in 2024 at $574 and has fallen 92.7% since, to $42 in 2025.
Across 122 payments — averaging $20.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$433
- AstraZeneca$159
- Sanofi$124
- Fujifilm Healthcare Americas Corporation$101
- Medtronic$80
- plus $369 from 8 others
Across 358 payments — averaging $4729.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$851K
- Janssen Research & Development, LLC$267K
- AbbVie$193K
- Genentech, Inc.$158K
- Bausch Health US, LLC$132K
- Gilead$44K
- plus $49K from 4 others
What the payments were for
- Travel & lodging$1255%
- Food & beverage$2,37595%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 68 | $1,234 |
| Johnson & Johnson | 28 | $433 |
| AstraZeneca | 3 | $159 |
| Sanofi | 1 | $124 |
| Fujifilm Healthcare Americas Corporation | 2 | $101 |
| Medtronic | 1 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $78 |
| Amgen | 2 | $65 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $60 |
| Bristol Myers Squibb | 3 | $56 |
| Gilead | 2 | $36 |
| Shire North American Group Inc | 2 | $32 |
| Pfizer | 2 | $24 |
| Daiichi Sankyo Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$124
How this compares
$2,500 in reported general payments places this provider in the 55th percentile of 935 gastroenterology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Esomeprazole Magnesium | 28 | $4,673 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 25 | $3,934 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 19 | $1,322 |
| Lansoprazole | 22 | $886 |
| Pantoprazole Sodium | 71 | $757 |
| Famotidine | 47 | $417 |
| Prochlorperazine Maleate | 335 | $400 |
| Omeprazole | 60 | $208 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Uniontown
- Miguel RegueiroPittsburgh$1.5M
- Adam PeytonAllentown$985K
- Shahin RahimianWaynesboro$592K
- Sandra El-HachemPittsburgh$472K
- Harshit KharaDanville$438K
- Kofi ClarkeHershey$426K
- Michael KochmanPhiladelphia$361K
- Gary LichtensteinPhiladelphia$342K
- Elie AounPittsburgh$323K
- Andrew TinsleyHershey$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.